Newman Dignan & Sheerar Inc. Reduces Stock Holdings in SPDR S&P Biotech ETF $XBI

Newman Dignan & Sheerar Inc. lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,581 shares of the exchange traded fund’s stock after selling 495 shares during the quarter. Newman Dignan & Sheerar Inc.’s holdings in SPDR S&P Biotech ETF were worth $712,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Wellington Management Group LLP raised its stake in SPDR S&P Biotech ETF by 24.1% during the 4th quarter. Wellington Management Group LLP now owns 65,250 shares of the exchange traded fund’s stock worth $5,876,000 after acquiring an additional 12,689 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of SPDR S&P Biotech ETF by 6,251.2% during the first quarter. GAMMA Investing LLC now owns 21,086 shares of the exchange traded fund’s stock worth $1,710,000 after purchasing an additional 20,754 shares during the last quarter. NBC Securities Inc. increased its position in shares of SPDR S&P Biotech ETF by 118,075.0% during the first quarter. NBC Securities Inc. now owns 4,727 shares of the exchange traded fund’s stock worth $383,000 after purchasing an additional 4,723 shares in the last quarter. Hennion & Walsh Asset Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 168.4% in the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 11,781 shares of the exchange traded fund’s stock valued at $955,000 after purchasing an additional 7,391 shares during the last quarter. Finally, Firethorn Wealth Partners LLC boosted its position in shares of SPDR S&P Biotech ETF by 8.5% in the 1st quarter. Firethorn Wealth Partners LLC now owns 9,598 shares of the exchange traded fund’s stock valued at $778,000 after purchasing an additional 751 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.2%

NYSEARCA:XBI opened at $101.39 on Thursday. The stock’s 50 day moving average price is $91.48 and its 200 day moving average price is $84.95. The company has a market capitalization of $5.52 billion, a PE ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.